Clinical Trial Update: Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer [NA]

View source ↗

Summary

This clinical trial update describes an individualized dose-escalation approach using 5-fluorouracil for gastrointestinal cancers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Cancer
• Appendiceal Cancer
• Colorectal Cancer
• Esophageal Cancer
• Small Bowel Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Colorectal Cancer, Esophagus Cancer | NA | Status: RECRUITING